Transdermal fentanyl recalled by various manufacturers.
Actavis Inc. is recalling 14 lots of transdermal fentanyl due to a defect which may cause the patches to leak fentanyl gel outside the reservoir. No injuries have been reported; however, exposure to the gel could put patients and caregivers at risk for serious adverse events including respiratory depression and possible overdose. The affected Actavis recalling all 25 mcg/hr lots of Duragesic transdermal fentanyl systems and all lots of 25 mcg/hr fentanyl patches sold by Sandoz, Inc. for the same reason. The affected
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.